恶性嗜铬细胞瘤的诊断进展
- 1、下载文档前请自行甄别文档内容的完整性，平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益，请联系客服反馈,我们会尽快为您处理(人工客服工作时间：9:00-18:30)。
万方数据
万方数据
万方数据
恶性嗜铬细胞瘤的诊断进展
作者：钟旭， 王卫庆， Zhong Xu， Wang Weiqing
作者单位：200025 上海交通大学医学院附属瑞金医院内分泌代谢病科,上海市内分泌代谢病临床医学中心,上海市内分泌代谢病研究所
刊名：
中华内分泌代谢杂志
英文刊名：Chinese Journal of Endocrinology and Metabolism
年，卷(期)：2014,30(6)
1.Korevaar TI;Grossman AB Pheochromocytomas and paragangliomas:assessment of malignant potential 2011
2.Ayala-Ramirez M;Feng L;Johnson MM Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas:primary tumor size and primary tumor location as prognostic indicators 2011
3.van der Harst E;de Herder W;de Krijger R The value of plasma markers for the clinical behaviour of phaeochromocytomas 2002
4.Gimm O;De Micco C;Perren A Malignant pheochromocytomas and paragangliomas:a diagnostic challenge 2012
5.Harari A;Inabnet Ⅲ WB Malignant pheochromocytoma:a review 2011
6.Eisenhofer G;Lenders JWM;Siegert G Plasma methoxytyramine:A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size,location and SDHB mutation status 2012
7.Ezuddin S;Fragkaki C MIBG and FDG PET findings in a patient with malignant pheochromocytoma:a significant discrepancy 2005
8.Bias I;Pacak K Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma 2004
9.Ilias I;Yu J;Carrasquillo JA Superiority of 6-[18F]-fluorodopamine positron emission tomography versus[131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma 2003
10.Timmers HJ;Chen CC;Carrasquillo JA Comparison of 18F-fluoro-L-DOPA,18F-fluoro-deoxyglucose,and 18F-fluorodopamine PET and 123 I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma 2009
11.Takano A;Oriuchi N;Tsushima Y Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging:comparison with 18 F-FDG positron emission tomography and 123I-MIBG scintigraphy 2008
12.Zelinka T;Musil Z;Du(s)ková J Metastatic pheochromocytoma:Does the size and age matter 2011
13.de Wailly P;Oragano L;Radé F Malignant pheochromocytoma:new malignancy criteria 2012
14.Thompson LDR Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms:a clinicopathologic and immunophenotypic study of 100 cases 2002
15.Agarwal A;Mehrotra PK;Jain M Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS):can they predict malignancy 2010
16.Wo D;Tischler AS;Lloyd RV Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score 2009
17.Astuti D;Latif F;Dallol A Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma 2001
18.Gimenez-Roqueplo AP;Favier J;Rustin P Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas 2003
19.Neumann HP;Pawlu C;Peczkowska M Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations 2004
20.van Nederveen FH;Gaal J;Favier J An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB,SDHC,or SDHD gene mutations:a retrospective and prospective analysis 2009